Search

everythinglearnresearchcommunity

for

Search:↓

Mutations in the NR3C1 gene cause a rare condition that affects hormone signaling and can lead to various symptoms, with dexamethasone as a treatment option.

EMT and metabolic pathways help cancer cells resist treatment and spread.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Understanding how skin cells react to pressure can help diagnose and manage pressure-related skin disorders.

Overactive Wnt5a disrupts hair follicle orientation in mice.

The protein AtRXR3 limits root hair growth in Arabidopsis, affecting phosphorus uptake.

Platycladus orientalis leaf extract helps hair grow by activating certain proteins.

CD34 is crucial for skin tumor development in mice.

CD34⁺ cells help heal damaged limbs by promoting blood vessel growth.

Smart delivery methods for CRISPR gene editing are crucial for clinical success.

Biomaterials can help heal wounds without scars and regenerate skin features.

Integrin α6 helps identify different neural crest cell types in the skin.

Understanding skin stem cells and their regulation is key to improving skin healing and treating disorders.

Substances from fat-derived stem cells can promote hair growth and counteract hormone-related hair loss by activating a key hair growth pathway.

Enhancing antioxidant responses can improve treatments for various diseases.

Feather follicles form through specific cellular flows and mechanical changes in the skin.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Genetic differences affect COVID-19 severity and treatment development.

JAK inhibitors show promise for treating skin diseases effectively and safely.

Blocking JAK-STAT signaling can lead to hair growth.

Disrupting Stat3 in hair follicle stem cells greatly reduces skin tumor formation.

Baricitinib is effective and safe for treating severe alopecia areata.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Generalized glucocorticoid resistance causes hormone imbalances and varied symptoms due to gene mutations.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

JAK inhibitors help treat alopecia areata but have high recurrence after stopping.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.